NIFTY  8,948.45  0.24%
  SENSEX  28,935.40  0.24%
 CURRENCY  Rs  66.97/$ 70.65/€, 83.29/£
  GOLD  29,199.00  -0.35%
  SILVER  42,670.00  -0.39%
  DAX  11,998.60  0.26%
  FTSE  7,302.25  0.38%
  CAC  4,895.88  0.12%
  HANG SENG  24,202.00  0.99%
  NIKKEI  19,379.90  -0.01%
  Shanghai Composite  3,261.22  0.13%
  DOW JONES  20,775.60  0.16%
  NASDAQ  5,860.63  -0.09%
  S&P 500  2,362.82  -0.11%
ANDREW FRERIS - It Will Be Unwise Of Fed To Hike Rates 3 Time This Year ANDREW FRERIS - Key Indices In U.S. Above Long-Term Moving Average

Awaiting Regulatory Approvals For Insulin Trials: Kiran Mazumdar Shaw

Video:

Play this video

July 26: Kiran Mazumdar Shaw, Chairman and MD at Biocon, talks about the progress made in the oral insulin trials. “We need to make sure there are no regulatory approval delays,” she says, adding that any such delay pushes the company behind its deadline.